Ambulatory Versus Home Blood Pressure Measurement

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2012 by University of Athens
Sponsor:
Information provided by (Responsible Party):
George S. Stergiou, University of Athens
ClinicalTrials.gov Identifier:
NCT01132001
First received: May 26, 2010
Last updated: October 9, 2012
Last verified: October 2012
  Purpose

This is a prospective study comparing the three blood pressure monitoring methods on the diagnosis of arterial hypertension. Blood pressure of each subject will be evaluated with clinic, home and 24h ambulatory blood pressure measurements in three visits


Condition
Arterial Hypertension

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: EVALUATION OF BLOOD PRESSURE MEASUREMENTS OUTSIDE OFFICE: COMPARISON OF DIAGNOSIS BASED ON EITHER AMBULATORY OR HOME BLOOD PRESSURE MEASUREMENTS

Resource links provided by NLM:


Further study details as provided by University of Athens:

Primary Outcome Measures:
  • Blood pressure monitoring methods [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Comparison among clinic, home and ambulatory blood pressure measurements.


Estimated Enrollment: 200
Study Start Date: October 2009
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   20 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects referred to an outpatient hyperetension clinic for arterial hypertension

Criteria

Inclusion Criteria:

  • Age > 20 yrs
  • Patients referred to an outpatient clinic for high blood pressure
  • Patients with no treatment or with antihypertensive treatment stable for at least 4 weeks.
  • Patients capable of performing home blood pressure measurements.
  • Signed informed consent

Exclusion Criteria:

  • Hypertension stage III (SBP>180 mmHg or DBP>110mmHg)
  • Secondary hypertension
  • Resistant hypertension
  • Arrhythmia
  • Pregnancy
  • Symptomatic heart disease
  • Renal disease (Cr>2mg/dl)
  • Uncontrolled diabetes mellitus (HbA1c>8.5%)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01132001

Contacts
Contact: George S Stergiou, MD +302107763117 gstergi@med.uoa.gr

Locations
Greece
Hypertension Center, Third Department of Medicine, University of Athens, Greece Recruiting
Athens, Greece
Contact: George S Stergiou, MD    +302107763117    gstergi@med.uoa.gr   
Principal Investigator: George S Stergiou, MD         
Sponsors and Collaborators
University of Athens
Investigators
Study Chair: George S Stergiou, MD Hypertension Center,Third Department of Medicine,University of Athens,Greece
  More Information

No publications provided

Responsible Party: George S. Stergiou, Associate Professor of Medicine and Hypertension, University of Athens
ClinicalTrials.gov Identifier: NCT01132001     History of Changes
Other Study ID Numbers: HBP5
Study First Received: May 26, 2010
Last Updated: October 9, 2012
Health Authority: Greece: Ethics Committee

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 26, 2014